Not enlarged the trial because they don't believe there will be a stop at first interim. Enlarged the trial to help speed participant uptake. Me referencing introduction of new sites was just musing that it wouldn't make sense to go through all that effort, only for the trial to stop for overwhelming efficacy.
Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-233
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.235(13.2%) |
Mkt cap ! $1.838B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $13.63M | 8.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 21002 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 6963 | 10 |
View Market Depth
| Last trade - 15.38pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |